Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/05/033866
CTRI/2021/05/033866
Not Yet Recruiting
N/A

A real world evidence based clinical management of heterogenous group of cancer patients in chemotherapy induced Adverse Drug Reactions (ADRs) by tho use of Rasayana Therapy-a prospective study

Rasayu Cancer Clinic Pune0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasayu Cancer Clinic Pune
Status
Not Yet Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Rasayu Cancer Clinic Pune

Eligibility Criteria

Inclusion Criteria

  • •1 Biopsy confirmed Diagnosed cases of carcinoma at any stage
  • •2 Have taken at least three cycle of Chemotherapy without Rasayana therapy and willing to take further cycles with Rasayana therapy or
  • •3 Patients have completed chemotherapy earlier and now willing to take chemotherapy and Rasayana therapy simultaneously
  • •4 Patient who are Advised to take same chemotherapy along with Rasayana
  • •5 Patients with intact cognitive functions who can recollect the intensity of adverse events or earlier chemotherapy
  • •6 Patients who have planned to Take CT cycle at least 15 days after initiation of Rasayana therapy

Exclusion Criteria

  • •Exclusion criteria
  • •1\.Patients taking radiotherapy
  • •2\. Patients taking another alternative therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
thaamani Nei(Internal) and Nellikkai thylam (External) in the management of Mantha Sanni (Autism spectrum disorder)
CTRI/2021/08/035524ational Institute of Siddha
Completed
N/A
A survey of healthcare professionals for evidence-based management of Complex Regional Pain Syndrome to improve clinical outcomes throughout the care pathwayComplex Regional Pain SyndromeMusculoskeletal Diseases
ISRCTN11618379niversity of the West of England77
Enrolling by Invitation
N/A
Effectiveness of an evidence-based care pathway to improve mobility and participation in older patients with vertigo and balance disorders in primary care (MobilE-PHY2): A multicentre cluster-randomised controlled trialR42H81R26R29.6F45.8Dizziness and giddinessDisorders of vestibular functionAbnormalities of gait and mobilityTendency to fall, not elsewhere classifiedOther somatoform disorders
DRKS00028524Technische Hochschule Rosenheim, Fakultät für Angewandte Gesundheits- und Sozialwissenschaften120
Not Yet Recruiting
Phase 2
STUDY ON SIDDHA MEDICINE TO MANAGE AND TREAT MENTAL AND BEHAVIOURAL PROBLEMS IN CHILDREHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
CTRI/2019/12/022286ational Institute of Siddha
Completed
Phase 3
Maha analuruva chooranam (internal) and Chennagarapattai ennai (external)for the management of Baalavatham(Paresis) in childreHealth Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
CTRI/2021/08/035549ational Institute of Siddha30